Importantly, two gene families of these amplified regions, PRAME and CT45, had been reported to overexpressed in various cancer types and associated with cancer metastasis6,9,17,31, indicating their potential as biomarkers for PM in GC patients. The gene discussed is PRAME; the disease is cancer.